4/A//SEC Filing
Early James 4/A
Accession 0001192482-19-000123
CIK 0001054102other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:16 PM ET
Size
8.0 KB
Accession
0001192482-19-000123
Insider Transaction Report
Form 4/AAmended
Early James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-12-05+12,000→ 12,000 totalExercise: $1.08Exp: 2028-12-05→ Common Stock (12,000 underlying) - Award
Common Stock
2018-12-05+3,000→ 17,000 total
Footnotes (4)
- [F1]On December 6, 2018, the award of restricted stock units was inadvertently omitted from the reporting person's Form 4 filing. The restricted stock units vest annually, in equal installments, over a three-year period, commencing on December 5, 2019.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
- [F3]On December 6, 2018, the award of stock options was inadvertently overstated on the reporting person's Form 4 filing as 15,000 stock options. 12,000 stock options were awarded.
- [F4]The stock options vest and become exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.
Documents
Issuer
Interpace Diagnostics Group, Inc.
CIK 0001054102
Entity typeother
Related Parties
1- filerCIK 0001687977
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:16 PM ET
- Size
- 8.0 KB